AKT3 expression in breast cancer is associated with an ER-negative receptor status in breast cancer cell lines and human samples, suggesting AKT3 contributes to aggressiveness in hormone receptor negative breast cancer [99]. This evidence concerns the gene AKT3 and breast cancer.